SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-21-000077
Filing Date
2021-01-28
Accepted
2021-01-28 14:17:52
Documents
40
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT FOR 12-31-2020 form_10-q.htm 10-Q 288772
2 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION ex_31-1.htm EX-31 5683
3 SECTION 1350 CERTIFICATION ex_32-1.htm EX-32 3583
4 GRAPHIC angiosoma-logo.jpg GRAPHIC 12338
  Complete submission text file 0001161697-21-000077.txt   1603234

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE soan-20201231.xml EX-101.INS 182794
6 XBRL SCHEMA FILE soan-20201231.xsd EX-101.SCH 18735
7 XBRL CALCULATION FILE soan-20201231_cal.xml EX-101.CAL 28292
8 XBRL DEFINITION FILE soan-20201231_def.xml EX-101.DEF 103067
9 XBRL LABEL FILE soan-20201231_lab.xml EX-101.LAB 145500
10 XBRL PRESENTATION FILE soan-20201231_pre.xml EX-101.PRE 134629
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 21564142
SIC: 2834 Pharmaceutical Preparations